Cargando…

FOXC1: an emerging marker and therapeutic target for cancer

The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Bingchen, Bhowmick, Neil, Qu, Ying, Chung, Stacey, Giuliano, Armando E., Cui, Xiaojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652000/
https://www.ncbi.nlm.nih.gov/pubmed/28288141
http://dx.doi.org/10.1038/onc.2017.48
_version_ 1783272985791037440
author Han, Bingchen
Bhowmick, Neil
Qu, Ying
Chung, Stacey
Giuliano, Armando E.
Cui, Xiaojiang
author_facet Han, Bingchen
Bhowmick, Neil
Qu, Ying
Chung, Stacey
Giuliano, Armando E.
Cui, Xiaojiang
author_sort Han, Bingchen
collection PubMed
description The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC as well as the implications of these new findings in cancer diagnosis and treatment.
format Online
Article
Text
id pubmed-5652000
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-56520002017-10-23 FOXC1: an emerging marker and therapeutic target for cancer Han, Bingchen Bhowmick, Neil Qu, Ying Chung, Stacey Giuliano, Armando E. Cui, Xiaojiang Oncogene Article The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC as well as the implications of these new findings in cancer diagnosis and treatment. 2017-03-13 2017-07-13 /pmc/articles/PMC5652000/ /pubmed/28288141 http://dx.doi.org/10.1038/onc.2017.48 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Han, Bingchen
Bhowmick, Neil
Qu, Ying
Chung, Stacey
Giuliano, Armando E.
Cui, Xiaojiang
FOXC1: an emerging marker and therapeutic target for cancer
title FOXC1: an emerging marker and therapeutic target for cancer
title_full FOXC1: an emerging marker and therapeutic target for cancer
title_fullStr FOXC1: an emerging marker and therapeutic target for cancer
title_full_unstemmed FOXC1: an emerging marker and therapeutic target for cancer
title_short FOXC1: an emerging marker and therapeutic target for cancer
title_sort foxc1: an emerging marker and therapeutic target for cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652000/
https://www.ncbi.nlm.nih.gov/pubmed/28288141
http://dx.doi.org/10.1038/onc.2017.48
work_keys_str_mv AT hanbingchen foxc1anemergingmarkerandtherapeutictargetforcancer
AT bhowmickneil foxc1anemergingmarkerandtherapeutictargetforcancer
AT quying foxc1anemergingmarkerandtherapeutictargetforcancer
AT chungstacey foxc1anemergingmarkerandtherapeutictargetforcancer
AT giulianoarmandoe foxc1anemergingmarkerandtherapeutictargetforcancer
AT cuixiaojiang foxc1anemergingmarkerandtherapeutictargetforcancer